801 related articles for article (PubMed ID: 25450583)
1. Oral coenzyme Q10 supplementation in patients with nonalcoholic fatty liver disease: effects on serum vaspin, chemerin, pentraxin 3, insulin resistance and oxidative stress.
Farhangi MA; Alipour B; Jafarvand E; Khoshbaten M
Arch Med Res; 2014 Oct; 45(7):589-95. PubMed ID: 25450583
[TBL] [Abstract][Full Text] [Related]
2. Functions of Coenzyme Q10 Supplementation on Liver Enzymes, Markers of Systemic Inflammation, and Adipokines in Patients Affected by Nonalcoholic Fatty Liver Disease: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial.
Farsi F; Mohammadshahi M; Alavinejad P; Rezazadeh A; Zarei M; Engali KA
J Am Coll Nutr; 2016; 35(4):346-53. PubMed ID: 26156412
[TBL] [Abstract][Full Text] [Related]
3. The effects of coenzyme Q10 administration on glucose homeostasis parameters, lipid profiles, biomarkers of inflammation and oxidative stress in patients with metabolic syndrome.
Raygan F; Rezavandi Z; Dadkhah Tehrani S; Farrokhian A; Asemi Z
Eur J Nutr; 2016 Dec; 55(8):2357-2364. PubMed ID: 26385228
[TBL] [Abstract][Full Text] [Related]
4. Serum chemerin and vaspin in non-alcoholic fatty liver disease.
Kukla M; Zwirska-Korczala K; Hartleb M; Waluga M; Chwist A; Kajor M; Ciupinska-Kajor M; Berdowska A; Wozniak-Grygiel E; Buldak R
Scand J Gastroenterol; 2010; 45(2):235-42. PubMed ID: 20095887
[TBL] [Abstract][Full Text] [Related]
5. Irisin in patients with nonalcoholic fatty liver disease.
Polyzos SA; Kountouras J; Anastasilakis AD; Geladari EV; Mantzoros CS
Metabolism; 2014 Feb; 63(2):207-17. PubMed ID: 24140091
[TBL] [Abstract][Full Text] [Related]
6. Cinnamon may have therapeutic benefits on lipid profile, liver enzymes, insulin resistance, and high-sensitivity C-reactive protein in nonalcoholic fatty liver disease patients.
Askari F; Rashidkhani B; Hekmatdoost A
Nutr Res; 2014 Feb; 34(2):143-8. PubMed ID: 24461315
[TBL] [Abstract][Full Text] [Related]
7. Effect of sour tea supplementation on liver enzymes, lipid profile, blood pressure, and antioxidant status in patients with non-alcoholic fatty liver disease: A double-blind randomized controlled clinical trial.
Izadi F; Farrokhzad A; Tamizifar B; Tarrahi MJ; Entezari MH
Phytother Res; 2021 Jan; 35(1):477-485. PubMed ID: 32909326
[TBL] [Abstract][Full Text] [Related]
8. Effects of Coenzyme Q10 Supplementation on Inflammatory Cytokines (TNF-α, IL-6) and Oxidative Stress in Rheumatoid Arthritis Patients: A Randomized Controlled Trial.
Abdollahzad H; Aghdashi MA; Asghari Jafarabadi M; Alipour B
Arch Med Res; 2015 Oct; 46(7):527-33. PubMed ID: 26342738
[TBL] [Abstract][Full Text] [Related]
9. Effects of Delta-tocotrienol Supplementation on Liver Enzymes, Inflammation, Oxidative stress and Hepatic Steatosis in Patients with Nonalcoholic Fatty Liver Disease.
Pervez MA; Khan DA; Ijaz A; Khan S
Turk J Gastroenterol; 2018 Mar; 29(2):170-176. PubMed ID: 29749323
[TBL] [Abstract][Full Text] [Related]
10. The effect of saffron supplementation on some inflammatory and oxidative markers, leptin, adiponectin, and body composition in patients with nonalcoholic fatty liver disease: A double-blind randomized clinical trial.
Pour FK; Aryaeian N; Mokhtare M; Mirnasrollahi Parsa RS; Jannani L; Agah S; Fallah S; Moradi N
Phytother Res; 2020 Dec; 34(12):3367-3378. PubMed ID: 32798261
[TBL] [Abstract][Full Text] [Related]
11. Anthropometric measures of visceral and subcutaneous fat are important in the determination of metabolic dysregulation in boys and girls at risk for nonalcoholic fatty liver disease.
Mager DR; Yap J; Rodriguez-Dimitrescu C; Mazurak V; Ball G; Gilmour S
Nutr Clin Pract; 2013 Feb; 28(1):101-11. PubMed ID: 23042833
[TBL] [Abstract][Full Text] [Related]
12. The effects of green cardamom on blood glucose indices, lipids, inflammatory factors, paraxonase-1, sirtuin-1, and irisin in patients with nonalcoholic fatty liver disease and obesity: study protocol for a randomized controlled trial.
Daneshi-Maskooni M; Keshavarz SA; Mansouri S; Qorbani M; Alavian SM; Badri-Fariman M; Jazayeri-Tehrani SA; Sotoudeh G
Trials; 2017 Jun; 18(1):260. PubMed ID: 28592311
[TBL] [Abstract][Full Text] [Related]
13. Effects of Coenzyme Q10 Supplementation on Exercise Performance and Markers of Oxidative Stress in Hemodialysis Patients: A Double-Blind Placebo-Controlled Crossover Trial.
Gokbel H; Turk S; Okudan N; Atalay H; Belviranli M; Gaipov A; Solak Y
Am J Ther; 2016; 23(6):e1736-e1743. PubMed ID: 26844861
[TBL] [Abstract][Full Text] [Related]
14. Acetyl-L-carnitine and lipoic acid improve mitochondrial abnormalities and serum levels of liver enzymes in a mouse model of nonalcoholic fatty liver disease.
Kathirvel E; Morgan K; French SW; Morgan TR
Nutr Res; 2013 Nov; 33(11):932-41. PubMed ID: 24176233
[TBL] [Abstract][Full Text] [Related]
15. Effects of coenzyme Q10 supplementation on antioxidant capacity and inflammation in hepatocellular carcinoma patients after surgery: a randomized, placebo-controlled trial.
Liu HT; Huang YC; Cheng SB; Huang YT; Lin PT
Nutr J; 2016 Oct; 15(1):85. PubMed ID: 27716246
[TBL] [Abstract][Full Text] [Related]
16. The effects of Zataria multiflora Boiss. (Shirazi thyme) on nonalcoholic fatty liver disease and insulin resistance: A randomized double-blind placebo-controlled clinical trial.
Zamani N; Shams M; Nimrouzi M; Zarshenas MM; Abolhasani Foroughi A; Fallahzadeh Abarghooei E; Fattahi MR
Complement Ther Med; 2018 Dec; 41():118-123. PubMed ID: 30477827
[TBL] [Abstract][Full Text] [Related]
17. Glucose homeostasis, insulin resistance and inflammatory biomarkers in patients with non-alcoholic fatty liver disease: Beneficial effects of supplementation with microalgae Chlorella vulgaris: A double-blind placebo-controlled randomized clinical trial.
Ebrahimi-Mameghani M; Sadeghi Z; Abbasalizad Farhangi M; Vaghef-Mehrabany E; Aliashrafi S
Clin Nutr; 2017 Aug; 36(4):1001-1006. PubMed ID: 27475283
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and Safety of Phytosomal Curcumin in Non-Alcoholic Fatty Liver Disease: A Randomized Controlled Trial.
Panahi Y; Kianpour P; Mohtashami R; Jafari R; Simental-Mendía LE; Sahebkar A
Drug Res (Stuttg); 2017 Apr; 67(4):244-251. PubMed ID: 28158893
[TBL] [Abstract][Full Text] [Related]
19. Genistein supplementation improves insulin resistance and inflammatory state in non-alcoholic fatty liver patients: A randomized, controlled trial.
Amanat S; Eftekhari MH; Fararouei M; Bagheri Lankarani K; Massoumi SJ
Clin Nutr; 2018 Aug; 37(4):1210-1215. PubMed ID: 28647291
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of synbiotic supplementation in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis of clinical trials: Synbiotic supplementation and NAFLD.
Hadi A; Mohammadi H; Miraghajani M; Ghaedi E
Crit Rev Food Sci Nutr; 2019; 59(15):2494-2505. PubMed ID: 29584449
[No Abstract] [Full Text] [Related]
[Next] [New Search]
